Polypid LTD Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Ori Warshavsky, Chief Operating Officer - US of PolyPid Ltd., received 46,000 shares of common stock on May 11, 2026.
NASDAQ
Jonathan Missulawin, Chief Financial Officer of PolyPid Ltd., received 49,000 shares of common stock on May 11, 2026.
NASDAQ
Dalit Fellous Hazan, Deputy CEO, EVP, RD, CRA of PolyPid Ltd., received 75,000 shares of common stock on May 11, 2026.
NASDAQ
Yechezkel Barenholz, a Director of PolyPid Ltd., received 9,132 shares of common stock on July 15, 2026.
NASDAQ
Robert Benjamin Stein, a Director of PolyPid Ltd., received 9,132 shares of common stock on July 15, 2026.
NASDAQ
Nir Dror-Darwish, a Director of PolyPid Ltd., received 9,132 shares of common stock on July 15, 2026.
NASDAQ
Joseph Benamram, a Director of PolyPid Ltd., received 9,132 shares of common stock on July 15, 2026.
NASDAQ
Itzhak Krinsky, a Director of PolyPid Ltd., received 9,132 shares of common stock on July 15, 2026.
NASDAQ
Brooke Story, a Director of PolyPid Ltd., received 9,132 shares of common stock on July 15, 2026.
NASDAQ
Dikla Czaczkes Akselbrad, Chief Executive Officer and a Director of PolyPid Ltd., received 149,000 shares of common stock on July 15, 2026.